The Vanguard Group 13D/13G Filings for Aerie Pharmaceuticals, Inc. (AERI)

The Vanguard Group 13D and 13G filings for Aerie Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-09
3:16 pm
Sale
2021-12-31 13G Aerie Pharmaceuticals, Inc.
AERI
The Vanguard Group 3,381,368
7.140%
-835,703decrease
(-19.82%)
Filing
2021-02-10
10:30 am
Sale
2020-12-31 13G Aerie Pharmaceuticals, Inc.
AERI
The Vanguard Group 4,217,071
9.010%
-20,420decrease
(-0.48%)
Filing